FDA Approves Olanzapine and Samidorphan for Schizophrenia, Bipolar I Disorder

Press/Media

Period	1 Jun 2021

Media coverage

Title	FDA Approves Olanzapine and Samidorphan for Schizophrenia, Bipolar I Disorder
Media name/outlet	HCPLive
Country/Territory	United States
Date	1/06/21
URL	https://www.hcplive.com/view/fda-approves-olanzapine-samidorphan-schizophrenia-bipolar-disorder
Persons	René S. Kahn, René S. Kahn, Rene Kahn